Cereno Scientific’s CEO Sten. R Sörensen announced as Leader of the Year by GU Ventures Awards

20 December, 2019

Today, GU Ventures Awards announced Sten R. Sörensen as the recipient of the award Leader of the Year with the below motivation.

Leader of the Year 2019:

Sten R Sörensen, CEO of Cereno Scientific AB

Cereno Scientific, which is a listed company, is developing a platform for cardiovascular therapy in the new field of epigenetics based on HDAC inhibitors.

With the company previously concentrated on preventing thrombosis, 2019 has meant a broadening of its focus. Now, it also includes rare diseases associated with, in addition to thrombosis, also fibrosis, inflammation and high blood pressure in the lung. The company has expanded its pipeline with the acquisition of two new preclinical projects with new innovative pharmaceutical compounds.

During the year, Sten has succeeded in attracting new resources when it comes to personnel on the international arena, as well as capital, projects and partners. This has lifted the company to a more visible position on an international level. Sten has also successfully led the team to deliver on promised milestones and significantly accelerated development, as well as having ensured that the company can begin its clinical trial which is to be conducted at 30 clinics in two countries and will be initiated during 2020.

Cereno Scientific was also one of the finalists regarding the award Best Team.

Read more here (in Swedish).